Printer Friendly

Articles from Stem Cell Business News (October 6, 2014)

1-20 out of 20 article(s)
Title Author Type Words
Better way to create pluripotent stem cells from adult cells. 689
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. 160
Cardio3 discusses new BusDev strategy. 102
Cell isolation/separation market to be worth $5.1 b by 2019. 376
Companies agree to joint development of therapy for stroke. 321
Final patient treated in Stargardt's macular degeneration phase 1 trial in U.K. 129
Global biotech market to grow at CAGR of 16.7 percent. Industry overview 364
Global stem cell therapy market growing at 39.5 percent CAGR. Industry overview 536
Graft-versus-host disease market to reach $409 m in four years. 358
ISCO reports on status of Parkinson's disease program. 227
JCR pharmaceuticals files for Japanese marketing approval of stem cell product. 215
Kadimastem reports to FDA on results of preclinical ALS treatment studies. 213
Last patient treated in BrainStorm's phase 2a ALS study. 242
NeoStem borrows $20 million. 180
Researchers receive $5.8 m federal grant to build 3D liver model. 414
Stemedica: patent for use of multiple stem cell lines to treat ischemic stroke. 257
Stemgent sells reagent and services business unit. Company overview 128
Therapy-grade stem cells created using new cocktail to reprogram adult cells. 451
U.K. centre to develop smart cell processing technologies. 256
Using skin cells to engineer pulmonary valves for pediatric heart patients. 412

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |